4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001140361-16-085049
CIK 0001335103operating
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 2:25 PM ET
Size
9.9 KB
Accession
0001140361-16-085049
Insider Transaction Report
Form 4
TURNER STEPHEN C
DirectorCEO and Chairman of the Board
Transactions
- Award
Common Stock
2016-11-03$0.07/sh+533,333$40,000→ 533,333 total(indirect: By Spouse) - Purchase
Class A Warrant to Purchase Common Stock
2016-11-03$0.07/sh+533,333$40,000→ 533,333 total(indirect: By Spouse)Exercise: $0.09From: 2016-11-03Exp: 2017-05-03→ Common Stock (533,333 underlying) - Award
Class B Warrant to Purchase Common Stock
2016-11-03$0.07/sh+533,333$40,000→ 533,333 total(indirect: By Spouse)Exercise: $0.11From: 2016-11-03Exp: 2021-11-03→ Common Stock (533,333 underlying)
Footnotes (1)
- [F1]The spouse of Reporting Person purchased 4 Units of the Issuer's securities for an aggregate purchase price of $40,000, each Unit consisting of (a) 133,333.33 shares of common stock, par value $0.0001 per share (the "Common Stock"), (b) 18 month warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.09 per share (the "Class A Warrants"), and (c) five year warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.1125 per share (the "Class B Warrants").
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 2:25 PM ET
- Size
- 9.9 KB